Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207657631> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3207657631 abstract "This study examined the safety, tolerability, and pharmacokinetics (PK) of napabucasin in healthy Asian and non-Asian participants and investigated the potential for QT/QTc interval prolongation. This five-part (A-E) study proceeded in a stepwise manner, unless stopping criteria were met. Parts A-D were randomized, double-blind, placebo-controlled, and included healthy Asian male and female and non-Asian male participants. PK parameters were measured following single-dose napabucasin (80-1200 mg) in the fasted or fed state (Part D). Potential QT/QTc interval prolongation was assessed using digital 12-lead electrocardiogram (Parts B and C). Part E was open-label, and examined the PK of single-dose napabucasin (240-720 mg) in healthy non-Asian males. Safety and tolerability were measured in Parts A-E. Changes from baseline in the Fridericia-corrected QT interval (ΔQTcF) and other electrocardiogram parameters were analyzed using a linear mixed-effects model. Napabucasin was well-tolerated across the study (n = 70), and no serious adverse events or significant safety issues were reported when administered with or without food. The most frequent treatment-emergent adverse events were diarrhea and abdominal pain, and these were mild in severity. No prolongation of the QTcF interval was reported following single-dose napabucasin (240-1200 mg) and changes in other cardiac parameters were negligible. The PK profile of napabucasin was consistent with earlier studies. Single-dose napabucasin was tolerated in healthy male and female participants, and no significant safety (including no QTcF prolongation) or tolerability issues were identified, irrespective of food intake. Clinical studies of napabucasin in advanced cancers are ongoing." @default.
- W3207657631 created "2021-10-25" @default.
- W3207657631 creator A5004190318 @default.
- W3207657631 creator A5015674533 @default.
- W3207657631 creator A5027017196 @default.
- W3207657631 creator A5030162184 @default.
- W3207657631 creator A5030453239 @default.
- W3207657631 creator A5044916041 @default.
- W3207657631 creator A5074544968 @default.
- W3207657631 creator A5078806780 @default.
- W3207657631 date "2021-10-01" @default.
- W3207657631 modified "2023-09-25" @default.
- W3207657631 title "Effects of a reactive oxygen species generator, napabucasin (BBI608), on tolerability, safety, pharmacokinetics, and QT/QTc interval in healthy volunteers" @default.
- W3207657631 cites W2002941893 @default.
- W3207657631 cites W2124966943 @default.
- W3207657631 cites W2596835303 @default.
- W3207657631 cites W2892095285 @default.
- W3207657631 cites W2942225848 @default.
- W3207657631 cites W2943079517 @default.
- W3207657631 cites W2978787292 @default.
- W3207657631 cites W3014674264 @default.
- W3207657631 doi "https://doi.org/10.1002/prp2.874" @default.
- W3207657631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8502439" @default.
- W3207657631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34628720" @default.
- W3207657631 hasPublicationYear "2021" @default.
- W3207657631 type Work @default.
- W3207657631 sameAs 3207657631 @default.
- W3207657631 citedByCount "4" @default.
- W3207657631 countsByYear W32076576312022 @default.
- W3207657631 countsByYear W32076576312023 @default.
- W3207657631 crossrefType "journal-article" @default.
- W3207657631 hasAuthorship W3207657631A5004190318 @default.
- W3207657631 hasAuthorship W3207657631A5015674533 @default.
- W3207657631 hasAuthorship W3207657631A5027017196 @default.
- W3207657631 hasAuthorship W3207657631A5030162184 @default.
- W3207657631 hasAuthorship W3207657631A5030453239 @default.
- W3207657631 hasAuthorship W3207657631A5044916041 @default.
- W3207657631 hasAuthorship W3207657631A5074544968 @default.
- W3207657631 hasAuthorship W3207657631A5078806780 @default.
- W3207657631 hasBestOaLocation W32076576312 @default.
- W3207657631 hasConcept C112705442 @default.
- W3207657631 hasConcept C118441451 @default.
- W3207657631 hasConcept C126322002 @default.
- W3207657631 hasConcept C197934379 @default.
- W3207657631 hasConcept C2778375690 @default.
- W3207657631 hasConcept C42219234 @default.
- W3207657631 hasConcept C71924100 @default.
- W3207657631 hasConcept C98274493 @default.
- W3207657631 hasConceptScore W3207657631C112705442 @default.
- W3207657631 hasConceptScore W3207657631C118441451 @default.
- W3207657631 hasConceptScore W3207657631C126322002 @default.
- W3207657631 hasConceptScore W3207657631C197934379 @default.
- W3207657631 hasConceptScore W3207657631C2778375690 @default.
- W3207657631 hasConceptScore W3207657631C42219234 @default.
- W3207657631 hasConceptScore W3207657631C71924100 @default.
- W3207657631 hasConceptScore W3207657631C98274493 @default.
- W3207657631 hasFunder F4320321627 @default.
- W3207657631 hasIssue "5" @default.
- W3207657631 hasLocation W32076576311 @default.
- W3207657631 hasLocation W32076576312 @default.
- W3207657631 hasLocation W32076576313 @default.
- W3207657631 hasOpenAccess W3207657631 @default.
- W3207657631 hasPrimaryLocation W32076576311 @default.
- W3207657631 hasRelatedWork W2037576960 @default.
- W3207657631 hasRelatedWork W2074207917 @default.
- W3207657631 hasRelatedWork W2087240036 @default.
- W3207657631 hasRelatedWork W2285479586 @default.
- W3207657631 hasRelatedWork W2396178441 @default.
- W3207657631 hasRelatedWork W4205587618 @default.
- W3207657631 hasRelatedWork W4253098345 @default.
- W3207657631 hasRelatedWork W4296087748 @default.
- W3207657631 hasRelatedWork W4366822339 @default.
- W3207657631 hasRelatedWork W4379260174 @default.
- W3207657631 hasVolume "9" @default.
- W3207657631 isParatext "false" @default.
- W3207657631 isRetracted "false" @default.
- W3207657631 magId "3207657631" @default.
- W3207657631 workType "article" @default.